Collaborate with Hikari
Partnerships
We're engaging pharmaceutical, biotechnology, government, and research partners to explore strategic collaboration opportunities around NAGOMI™.
Strategic collaboration opportunities
Building the interface for medicines that can be controlled non-invasively after administration.
Hikari Medical Technologies is engaging pharmaceutical, biotechnology, government, and research partners to explore strategic collaboration opportunities around NAGOMI™, our noninvasive precision dosing platform. We are especially interested in partners developing or commercializing therapies limited by dosing burden, toxicity, PK variability, narrow therapeutic windows, or administration complexity.
Potential collaboration areas
- Feasibility studies
- Drug candidate evaluation
- Co-development
- Strategic investment
- Platform partnerships
Ecosystem
Current and former sponsors and collaborators
BARDA
U.S. Biomedical Advanced Research & Development Authority
DoD
Dual-Use Initiative
California GO-Biz
Governor's Office Of Business & Economic Development
Plug and Play
Global Innovation Platform
NSF I-Corps
National Science Foundation
University Lab Partners
I-CREATE Accelerator Network Hub
CNSI
California NanoSystems Institute — UCSB & UCLA Incubators
Cal Poly CIE
Center For Innovation And Entrepreneurship — HotHouse Incubator
University of Tokyo
Research Collaboration
Logos and names shown represent current or former sponsors, collaborators, or ecosystem partners. Inclusion does not imply endorsement unless otherwise stated.